St. Vincent’s Riverside is now offering a breakthrough treatment for patients diagnosed with chronic pulmonary obstructive ...

Boehringer Ingelheim’s lung disease drug nerandomilast has been successful in a Phase III study paving the way for the ...

Most importantly, the presence of albuminuria increased the risk for restrictive lung disease (OR 8.57) as compared to non-diabetic patients (Figure 1B). Multidetector computed tomography confirmed ...

All problems (adverse events) related to a medicine or medical device used for treatment or in a procedure should be reported to the Medicines and Healthcare products Regulatory Agency using the ...

Comprehensive approaches including large-scale screening and targeted treatments are essential to reduce lung cancer mortality.

identification of specific phenotypes or ‘treatable traits’ in patients with established disease, and (3) identification of response to treatment. We provide an overview of established techniques for ...

For both research and clinical purposes, measures of lung involvement should ideally be (1) sensitive enough to detect abnormalities early and directly reflect changes in disease severity, either ...

COPD is a progressive lung disease with mild symptoms in the early stages that gradually worsen. Early diagnosis and treatment can help preserve lung function. People with COPD often have trouble ...

The death of former U.S. President Jimmy Carter at the end of 2024 brought an outpouring of gratitude for his work on neglected tropical diseases ... a straightforward treatment you can give ...

Novel therapies targeting molecular pathways, including DLL3 and PARP inhibitors, show promise in improving SCLC survival outcomes. Tarlatamab, a DLL3-targeting bispecific T-cell engager, achieved ...

HealthDay News — In a clinical practice guideline issued by the American Thoracic Society and published in the January issue of the American Journal of Respiratory and Critical Care Medicine, updated ...

The aim is to develop personalised treatments for Asian patients with chronic lung disease, and augment the development of national and regional strategies to improve lung health, particularly for ...